NEW YORK (360Dx) – Klaris Diagnostics today announced the completion of a $3.75 million Series A financing round to support continued development of its rapid antibiotic susceptibility testing platform.
The financing was led by Omnimed Capital.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.